AstraZeneca PLC
1557.00
30-January-25 10:24:53
15 minutes delayed
Stocks
+16.50
+1.07%
Today's range
1534.00 - 1558.00
ISIN
N/A
Source
Cboe
-
22 Sep 2023 04:43:29 By MarketWatch
-
AstraZeneca Reports Positive Results From Phase III Trial With Datopotamab Deruxtecan
22 Sep 2023 01:59:00 By NASDAQ US Markets
-
AZN : Phase III Trial Of FASENRA In Eosinophilic Granulomatosis With Polyangiitis Meets Main Goal
11 Sep 2023 22:09:20 By NASDAQ US Markets
-
AstraZeneca's Tagrisso Plus Chemotherapy Extended Median PFS In EGFR-mutated Advanced Lung Cancer
11 Sep 2023 03:44:24 By NASDAQ US Markets
-
AstraZeneca: FDA Issues CRL Regarding SBLA Of Ultomiris In NMOSD
06 Sep 2023 02:02:17 By NASDAQ US Markets
-
AstraZeneca's Calquence Approved In China For Chronic Lymphocytic Leukaemia
04 Sep 2023 02:53:41 By NASDAQ US Markets
-
AZN October 6th Options Begin Trading
24 Aug 2023 11:27:14 By NASDAQ Stocks
-
AstraZeneca Announces Approval Of Soliris In Japan For Expanded Use
24 Aug 2023 02:30:40 By NASDAQ US Markets
-
Is This Blue Chip Dividend Stock a Buy for Growth Investors?
08 Aug 2023 04:26:56 By NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q2 2023 Earnings Call Transcript
28 Jul 2023 14:14:43 By NASDAQ US Markets